Quick Answer
Intradermal allergy testing injects a small amount of allergen solution directly into the skin's dermis using a tuberculin syringe. It is approximately 100 times more sensitive than skin prick testing. It is used when skin prick tests are negative but allergy is still clinically suspected, and is the standard method for diagnosing insect venom allergy and many drug allergies.
How Intradermal Testing Differs From Skin Prick Testing
Skin prick testing (SPT) delivers allergen to the superficial epidermis through a superficial lance or prick — it is quick, relatively comfortable, and has low false-positive rates. Intradermal testing (IDT) injects 0.01–0.05 mL of a more dilute allergen solution directly into the dermis using a 26-27 gauge needle, producing a raised, blanched bleb approximately 3mm in diameter. The injection is more uncomfortable than prick testing.
Because IDT introduces allergen directly into the richly vascularized dermis where mast cells are abundant, it is 10–100 times more sensitive than SPT — it detects lower levels of allergen-specific IgE on skin mast cells. This higher sensitivity means IDT is more likely to detect sensitization in patients with lower IgE levels, but also more likely to produce false positives.
When Intradermal Testing Is Used
Intradermal testing is particularly valuable for diagnosing insect venom allergy (bee, yellow jacket, wasp, hornet, fire ant) — a clinical scenario where accurate sensitization detection is critical because venom immunotherapy can be life-saving. For venom allergy, IDT is performed after negative SPT to rule out venom sensitization in patients with a history of systemic reactions to stings.
Drug allergy evaluation (particularly for penicillin and cephalosporin allergy) routinely uses intradermal testing with major and minor penicillin determinants to identify patients with true IgE sensitization. IDT for food allergens is more controversial — it has a high false-positive rate for foods and generally should not be used routinely for food allergy diagnosis without specific clinical indication.
Risks and False Positive Concerns
Because of its higher sensitivity, IDT carries a higher risk of false-positive results, particularly for food allergens and at higher allergen concentrations. Irritant intradermal reactions (non-specific reactions from the concentration or diluent) are common if appropriate dilution protocols are not followed. This is why IDT for food allergy is not routinely recommended by AAAAI guidelines when SPT and blood testing are available.
IDT also carries a somewhat higher risk of systemic reactions than SPT because the allergen dose per injection is larger and is delivered more directly into circulation-accessible dermis. Emergency equipment must be immediately available during IDT, and the procedure should only be performed in allergy offices with trained personnel and epinephrine readily accessible.
Key Takeaways
- Intradermal testing is 10–100× more sensitive than skin prick testing — detects lower IgE levels.
- Primary uses: insect venom allergy diagnosis and drug allergy (penicillin) evaluation after negative SPT.
- Higher sensitivity means higher false-positive rate — IDT for food allergy has limited routine utility.
- IDT carries a higher systemic reaction risk than SPT — must be performed in allergy offices with emergency equipment.
- Standard dilution protocols are critical for IDT to distinguish true allergy from irritant reactions.
Related Guide
Allergy Testing Hub →